Exchange: NASDAQ·Updated 07:59 PM EDT
HROW logo

HROWHarrow Health Inc

$42.48
$0.45
(1.05%)
Today
Closed $42.48
$0.33
(0.78%)
After Hours
EarningsAug 10
Mkt Cap$1.58B
Vol411,360.00

About

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
373

Frequently Asked Questions

What is Market Cap of Harrow Inc?
What is the 52-week high for Harrow Inc?
What is the 52-week low for Harrow Inc?
What is Harrow Inc stock price today?
What was Harrow Inc stock price yesterday?
What is the PE ratio of Harrow Inc?
What is the Price-to-Book ratio of Harrow Inc?
What is the 50-day moving average of Harrow Inc?
How many employees does Harrow Inc have?